loading
전일 마감가:
$1.51
열려 있는:
$1.5
하루 거래량:
545.61K
Relative Volume:
0.37
시가총액:
$97.66M
수익:
-
순이익/손실:
$-292.19M
주가수익비율:
-0.315
EPS:
-4.54
순현금흐름:
$-208.41M
1주 성능:
+10.85%
1개월 성능:
-23.53%
6개월 성능:
-49.47%
1년 성능:
-86.98%
1일 변동 폭
Value
$1.41
$1.505
1주일 범위
Value
$1.275
$1.565
52주 변동 폭
Value
$1.01
$13.24

Zentalis Pharmaceuticals Inc Stock (ZNTL) Company Profile

Name
명칭
Zentalis Pharmaceuticals Inc
Name
전화
(858) 263-4333
Name
주소
10275 SCIENCE CENTER DRIVE, SAN DIEGO, NY
Name
직원
166
Name
트위터
@ZentalisP
Name
다음 수익 날짜
2025-03-26
Name
최신 SEC 제출 서류
Name
ZNTL's Discussions on Twitter

ZNTL을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
ZNTL
Zentalis Pharmaceuticals Inc
1.43 97.66M 0 -292.19M -208.41M -4.54
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
493.84 122.76B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
602.64 61.38B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
614.76 36.37B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
251.56 30.12B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
244.90 24.70B 3.81B -644.79M -669.77M -6.24

Zentalis Pharmaceuticals Inc Stock (ZNTL) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-08-12 업그레이드 Wedbush Underperform → Neutral
2024-06-20 다운그레이드 UBS Buy → Neutral
2024-06-18 다운그레이드 Jefferies Buy → Hold
2024-06-18 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2024-06-18 다운그레이드 Wedbush Neutral → Underperform
2024-06-18 다운그레이드 Wells Fargo Overweight → Equal Weight
2023-11-08 다운그레이드 Wedbush Outperform → Neutral
2023-11-07 다운그레이드 Leerink Partners Outperform → Market Perform
2022-07-12 개시 Cowen Outperform
2022-04-06 개시 Wells Fargo Overweight
2021-10-07 재개 Jefferies Buy
2021-09-30 개시 Stifel Buy
2021-09-29 개시 Oppenheimer Outperform
2021-05-21 개시 UBS Buy
2021-01-20 개시 Wedbush Outperform
2020-09-29 개시 Cantor Fitzgerald Overweight
2020-08-27 개시 H.C. Wainwright Buy
2020-04-28 개시 Guggenheim Buy
2020-04-28 개시 Jefferies Buy
2020-04-28 개시 Morgan Stanley Overweight
2020-04-28 개시 SVB Leerink Outperform
모두보기

Zentalis Pharmaceuticals Inc 주식(ZNTL)의 최신 뉴스

pulisher
03:55 AM

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Position Increased by Russell Investments Group Ltd. - Defense World

03:55 AM
pulisher
Apr 25, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 25, 2025
pulisher
Apr 24, 2025

Zentalis Pharmaceuticals Inc (ZNTL) deserves deeper analysis - uspostnews.com

Apr 24, 2025
pulisher
Apr 24, 2025

Chief Medical Officer Bruns Ingmar acquire 20,000 shares of Zentalis Pharmaceuticals Inc [ZNTL] - knoxdaily.com

Apr 24, 2025
pulisher
Apr 23, 2025

Zentalis Pharmaceuticals Announces Poster Presentation at 2025 ASCO Annual Meeting - The Manila Times

Apr 23, 2025
pulisher
Apr 23, 2025

Zentalis Pharmaceuticals Announces Poster Presentation at ASCO 2025 on Azenosertib for Colorectal Cancer - Nasdaq

Apr 23, 2025
pulisher
Apr 23, 2025

New Clinical Data: Zentalis's Novel Cancer Drug Shows Promise in Metastatic Colorectal Cancer Treatment - Stock Titan

Apr 23, 2025
pulisher
Apr 23, 2025

JPMorgan Chase & Co. Boosts Holdings in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) - Defense World

Apr 23, 2025
pulisher
Apr 19, 2025

Franklin Resources Inc. Buys Shares of 106,748 Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) - Defense World

Apr 19, 2025
pulisher
Apr 14, 2025

Raymond James Financial Inc. Takes Position in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) - Defense World

Apr 14, 2025
pulisher
Apr 12, 2025

12,840 Shares in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Acquired by Prudential Financial Inc. - Defense World

Apr 12, 2025
pulisher
Apr 12, 2025

Sei Investments Co. Purchases Shares of 35,320 Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) - Defense World

Apr 12, 2025
pulisher
Apr 10, 2025

Zentalis Pharmaceuticals Inc (NASDAQ: ZNTL): Can The Stock Still Lose Despite An -61.39% YTD Loss? - Marketing Sentinel

Apr 10, 2025
pulisher
Apr 08, 2025

Zentalis stock plunges to 52-week low at $1.08 amid market challenges - Investing.com Canada

Apr 08, 2025
pulisher
Apr 08, 2025

Lost Money on Zentalis Pharmaceuticals, Inc.(ZNTL)? You May Have Been Affected by FraudContact Levi & Korsinsky - ACCESS Newswire

Apr 08, 2025
pulisher
Apr 08, 2025

ZNTL INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Zentalis Pharmaceuticals, Inc. and Encourages Shareholders to Contact the Firm! - ACCESS Newswire

Apr 08, 2025
pulisher
Apr 05, 2025

Thrivent Financial for Lutherans Grows Stock Holdings in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) - Defense World

Apr 05, 2025
pulisher
Apr 03, 2025

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Given Average Rating of “Hold” by Brokerages - Defense World

Apr 03, 2025
pulisher
Apr 01, 2025

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Apr 01, 2025
pulisher
Apr 01, 2025

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - MarketScreener

Apr 01, 2025
pulisher
Apr 01, 2025

Zentalis Strengthens Team with $194,600 in Equity Incentives - Stock Titan

Apr 01, 2025
pulisher
Apr 01, 2025

Virtu Financial LLC Buys Shares of 24,973 Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) - Defense World

Apr 01, 2025
pulisher
Apr 01, 2025

Leerink Partnrs Issues Pessimistic Outlook for ZNTL Earnings - Defense World

Apr 01, 2025
pulisher
Mar 31, 2025

What is HC Wainwright’s Forecast for ZNTL Q1 Earnings? - Defense World

Mar 31, 2025
pulisher
Mar 31, 2025

Leerink Partnrs Has Pessimistic Outlook of ZNTL Q1 Earnings - Defense World

Mar 31, 2025
pulisher
Mar 30, 2025

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Position Lifted by Charles Schwab Investment Management Inc. - Defense World

Mar 30, 2025
pulisher
Mar 30, 2025

Wedbush Reiterates Neutral Rating for Zentalis Pharmaceuticals (NASDAQ:ZNTL) - Defense World

Mar 30, 2025
pulisher
Mar 28, 2025

Zentalis Pharmaceuticals: Hold Rating Amid Clinical Progress and Financial Uncertainty - TipRanks

Mar 28, 2025
pulisher
Mar 28, 2025

Bank of New York Mellon Corp Sells 10,375 Shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) - Defense World

Mar 28, 2025
pulisher
Mar 28, 2025

Zentalis Pharmaceuticals (NASDAQ:ZNTL) Receives “Buy” Rating from HC Wainwright - Defense World

Mar 28, 2025
pulisher
Mar 28, 2025

Zentalis Pharmaceuticals Reports Progress and Financials - TipRanks

Mar 28, 2025
pulisher
Mar 27, 2025

Stifel maintains Buy on Zentalis stock with $9 target By Investing.com - Investing.com Canada

Mar 27, 2025
pulisher
Mar 27, 2025

H.C. Wainwright sets $10 target for Zentalis shares, maintains Buy By Investing.com - Investing.com Canada

Mar 27, 2025
pulisher
Mar 27, 2025

Zentalis Pharmaceuticals Reports Full Year 2024 Financial Results and Operational Updates - The Manila Times

Mar 27, 2025
pulisher
Mar 26, 2025

Zentalis Pharmaceuticals Inc Reports Annual EPS of -$2.33, Excee - GuruFocus

Mar 26, 2025
pulisher
Mar 26, 2025

Zentalis Pharmaceuticals Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 26, 2025
pulisher
Mar 26, 2025

Zentalis Pharmaceuticals Inc Files For Mixed Shelf Of Up To $250 MillionSEC Filing - Marketscreener.com

Mar 26, 2025
pulisher
Mar 26, 2025

Zentalis Breakthrough: 35% Response Rate in Ovarian Cancer Trial Wins FDA Fast Track - Stock Titan

Mar 26, 2025
pulisher
Mar 25, 2025

Zentalis Pharmaceuticals to Present Multiple Posters at the American Association for Cancer Research (AACR) Annual Meeting 2025 - The Manila Times

Mar 25, 2025
pulisher
Mar 25, 2025

Zentalis Pharmaceuticals to Present Multiple Posters at the - GlobeNewswire

Mar 25, 2025
pulisher
Mar 25, 2025

Major Cancer Breakthrough: Zentalis Reveals New Azenosertib Data Across Multiple Tumor Types - Stock Titan

Mar 25, 2025
pulisher
Mar 21, 2025

Zentalis Pharmaceuticals Inc expected to post a loss of 71 cents a shareEarnings Preview - TradingView

Mar 21, 2025
pulisher
Mar 20, 2025

Zentalis pharmaceuticals director Luke Walker buys $24,966 in stock - MSN

Mar 20, 2025
pulisher
Mar 19, 2025

Zentalis Pharmaceuticals (NASDAQ:ZNTL) Earns Buy Rating from HC Wainwright - The AM Reporter

Mar 19, 2025
pulisher
Mar 17, 2025

H.C. Wainwright maintains $10 target on Zentalis stock By Investing.com - Investing.com Canada

Mar 17, 2025
pulisher
Mar 17, 2025

Zentalis Highlights Promising Azenosertib Data at SGO 2025 - TipRanks

Mar 17, 2025
pulisher
Mar 15, 2025

Zentalis Pharmaceuticals Presents Updated Clinical Data at - GlobeNewswire

Mar 15, 2025
pulisher
Mar 15, 2025

Zentalis Pharmaceuticals Presents Updated Clinical Data at the Society of Gynecologic Oncology 2025 Annual Meeting on Women's Cancer - MarketScreener

Mar 15, 2025
pulisher
Mar 15, 2025

Zentalis Announces Updated Clinical Data From Part 1b Of DENALI Trial Of Azenosertib In PROC - Nasdaq

Mar 15, 2025
pulisher
Mar 15, 2025

Zentalis Pharmaceuticals Presents Updated Clinical Data at the Society of Gynecologic Oncology 2025 Annual Meeting on Women’s Cancer - TradingView

Mar 15, 2025
pulisher
Mar 11, 2025

Zentalis Pharmaceuticals Inc (NASDAQ: ZNTL) Has Been Trading Down. What Are The Prospects For The Future? - stocksregister.com

Mar 11, 2025

Zentalis Pharmaceuticals Inc (ZNTL) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$20.59
price up icon 0.24%
$69.69
price up icon 1.06%
$32.20
price up icon 0.53%
$23.46
price down icon 36.06%
$102.02
price down icon 15.36%
biotechnology ONC
$244.90
price down icon 4.40%
자본화:     |  볼륨(24시간):